Elevated Creatine Phosphokinase in a Patient on a Long-Acting Antipsychotic
The Primary Care Companion For CNS Disorders · 2023
DOI: 10.4088/pcc.22cr03442 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Primary Care Companion For CNS Disorders, 2023. Verfasst von Sahar Ashraf und 6 weiteren Autor:innen. Beteiligte Einrichtung: Northpointe Psychiatry, Lewisville, Texas. Hauptthemen laut MEDLINE: Antipsychotic Agents, Neuroleptic Malignant Syndrome.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Northpointe Psychiatry, Lewisville, Texas.
- Corresponding Author: Sahar Ashraf, MD, Northpointe Psychiatry, 860 Hebron Pkwy, Ste 1101, Lewisville, TX 75057 (sahraf.1105@gmail.com).
- University of La Verne, California.
- Baptist Health-UAMS, North Little Rock, Arkansas.
- Wake Forest University, Winston-Salem, North Carolina.
- Boston Children's Hospital, Massachusetts.
Zitieren
APA
Ashraf, S., Kochhar, H., Jenson, C., Griffin, B., Shah, K., Mansuri, Z., & Bachu, A. (2023). Elevated Creatine Phosphokinase in a Patient on a Long-Acting Antipsychotic. The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.22cr03442
Vancouver
Ashraf S, Kochhar H, Jenson C, Griffin B, Shah K, Mansuri Z, et al. Elevated Creatine Phosphokinase in a Patient on a Long-Acting Antipsychotic. The Primary Care Companion For CNS Disorders. 2023. doi:10.4088/pcc.22cr03442
BibTeX
@article{Ashraf2023,
author = {Ashraf, Sahar and Kochhar, Hansini and Jenson, Charles and Griffin, Brittany and Shah, Kaushal and Mansuri, Zeeshan and Bachu, Anil},
title = {Elevated Creatine Phosphokinase in a Patient on a Long-Acting Antipsychotic},
journal = {The Primary Care Companion For CNS Disorders},
year = {2023},
doi = {10.4088/pcc.22cr03442}
}
EUVIMED